Stimulates bone formation and increases bone density
Ingredients
Teriparatide (recombinant human parathyroid hormone 1-34)
Suitable For
Individuals with osteoporosis particularly postmenopausal women and men at high risk for fractures
Use
Daily subcutaneous injection as prescribed by a healthcare provider
Age Group
Adults
Volume
2.4 mL (contains 28 daily doses of 20 micrograms each)
Shelf Life
28 days after the first use when stored under refrigeration between 2C to 8C
About Forteo Injection
Experience the power of Forteo Injection, designed for individuals with osteoporosis, especially postmenopausal women and men at high fracture risk. This innovative solution features Teriparatide, a recombinant human parathyroid hormone that stimulates bone formation and increases bone density effectively. Administered through daily subcutaneous injections as prescribed, each 2.4 mL vial holds 28 doses of 20 micrograms, catering to adult age groups. With a shelf life of 28 days post-first use when stored between 2C to 8C, Forteo Injection is a reliable choice for enhancing bone health.
FAQs of Forteo Injection:
Q: Who is Forteo Injection suitable for?
A: Forteo Injection is suitable for individuals with osteoporosis, particularly postmenopausal women and men at high risk for fractures.
Q: What are the key ingredients of Forteo Injection?
A: The main ingredient in Forteo Injection is Teriparatide, a recombinant human parathyroid hormone 1-34.
Q: How does Forteo Injection work?
A: Forteo Injection stimulates bone formation and increases bone density, aiding in the treatment of osteoporosis.
Q: What is the recommended usage of Forteo Injection?
A: Forteo Injection is meant for daily subcutaneous injections as prescribed by a healthcare provider.
Q: What is the shelf life and volume of Forteo Injection?
A: Forteo Injection has a shelf life of 28 days after the first use when stored under refrigeration and comes in a 2.4 mL vial containing 28 daily doses of 20 micrograms each.